publicações selecionadas
-
artigo académico
- A transcriptomic profiling reveals novel roles of Cadherin-3 in metabolic programming of glioblastoma 2024
- A transcriptomic profiling reveals novel roles of Cadherin-3 in metabolic programming of glioblastoma - in final phase of preparation 2024
- Exploring Glioma Heterogeneity: Integrative Multi-Omics Analysis to Discover Transcriptome-Methylome signatures 2024
- Updating TCGA glioma subtype classification through integration of molecular profiling data following 2016 and 2021 WHO guidelines 2024
- WNT6 drives mechanisms of aggressiveness and resistance to chemotherapy in human glioblastoma - in final phase of preparation 2024
-
documento
- Deciphering WNT6-driven mechanisms of aggressiveness and resistance to chemotherapy in human glioblastoma 2024
- Deciphering novel mechanisms of WNT6-driven chemotherapy resistance in human glioblastoma 2023
- A transcriptomic profiling reveals novel roles of Cadherin-3 in metabolic programming of glioblastoma 2023
- Unveiling the impact of the oncogenic molecule Cadherin-3 in the metabolism of human glioblastoma 2023
- Unveiling the impact of the oncogenic molecule Cadherin-3 in themetabolism of human glioblastoma 2023
- Role of the ubiquitin hydrolase ATXN3 in glioblastoma: a new tumor suppressor gene? 2022
- Cadherin-3 is a novel oncogenic biomarker with prognostic value in glioblastoma 2022
- CDH3/P-cadherin is a novel oncogenic biomarker with prognostic value in glioblastoma 2020
- Deciphering WNT6 up and down roads in glioblastoma: mechanistic, functional, and clinical insight 2020
- Functional and prognostic relevance of CDH3/P-cadherin in glioblastoma 2019
- Deciphering key roles of WNT6 in glioblastoma: mechanistic, functional, and clinical insights 2019
- CDH3/P-cadherin is an oncogenic biomarker in glioblastoma 2019
- CDH3/P-cadherin expression is associated with aggressiveness of human glioblastoma 2018
- CDH3/P-cadherin as a novel biomarker in glioblastoma: functional and prognostic insights 2018
- Functional impact and prognostic relevance of CDH3/P-cadherin in glioblastoma 2018
- CDH3/P-cadherin as a putative HOXA9 target in gliomas: functional and clinical relevance 2017